Revision of the Guidelines Subcommittee - \2IG1I9Q 
Others: 
Elizabeth Anderson, Environmental Protection Agency 
Thomas L. Copmann, Pharmaceutical Manufacturers Association 
Diane O. Fleming, Merck & Company, Inc. 
Mark Foglesong, Eli Lilly and Company 
Joseph R. Fordham, NOVA Nordisk Bioindustrials, Inc. 
Robert Goldberg, Merck Sharp & Dohme Research Laboratory 
Alan Goldhammer, Industrial Biotechnology Association 
William McMullen, NOVA Nordisk Biochem, Inc. 
Henry Miller, Food and Drug Administration 
Cheryl Sutterfield, Pharmaceutical Manufacturers Association 
Cary Ruscus, Blue Sheet 
Joseph Van Houten, Pharmaceutical Research Institute 
Recombinant DNA Research, Volume 14 
